Aescap Life Sciences
Amsterdam, Netherlands · Growth
Their stated focus (public profile)
Aescap manages liquid (publicly listed) biotech and life sciences funds focused on high-conviction portfolios of approximately 20 carefully selected growth companies. The funds target companies with proprietary technology, strong management, distinctive products with robust competitive edges, and significant unmet medical needs, with a particular emphasis on firms using AI to accelerate drug development. The strategy combines fundamental valuation, diversification across technologies and disease areas, and intensive ongoing monitoring.
Stages: Growth
Sectors: Life sciences, Healthtech
On file: 11 partners on record
Website: aescap.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.